ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,599.30
0.49%
US Tech 100
18,919.60
-0.82%
다우존스 지수
41,350.93
-0.20%
Bitcoin
82,909.39
-0.92%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Fluidigm Corporation (FLDM) 시세

Fluidigm Corporation

Fluidigm Corporation (FLDM)

Franklin International Multifactor Index ETF
3.71
0.00
(0.00%)
마감 13 3월 5:00AM
15분 지연
3.71
0.00
( 0.00% )
시간외 단일가: 9:00AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
3.71
매수가
3.69
매도가
4.03
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
market_cap
294.555M
전일 종가
3.71
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
79,395,000
배당수익률
-
주가수익률
-3.95
주당순이익(EPS)
-0.94
매출
106.34M
순이익
-74.66M

Fluidigm Corporation 정보

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Sl... Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific. 더 보기

섹터
Lab Analytical Instruments
산업
Lab Analytical Instruments
웹사이트
www.fluidigm.com
본부
Wilmington, Delaware, USA
설립됨
-

FLDM 최신 뉴스

추가 뉴스
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

FLDM - Frequently Asked Questions (FAQ)

What is the current Fluidigm share price?
The current share price of Fluidigm is US$ 3.71
How many Fluidigm shares are in issue?
Fluidigm has 79,395,000 shares in issue
What is the market cap of Fluidigm?
The market capitalisation of Fluidigm is USD 294.56M
What is the 1 year trading range for Fluidigm share price?
Fluidigm has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Fluidigm?
The price to earnings ratio of Fluidigm is -3.95
What is the cash to sales ratio of Fluidigm?
The cash to sales ratio of Fluidigm is 2.77
What is the reporting currency for Fluidigm?
Fluidigm reports financial results in USD
What is the latest annual turnover for Fluidigm?
The latest annual turnover of Fluidigm is USD 106.34M
What is the latest annual profit for Fluidigm?
The latest annual profit of Fluidigm is USD -74.66M
What is the registered address of Fluidigm?
The registered address for Fluidigm is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Fluidigm website address?
The website address for Fluidigm is www.fluidigm.com
Which industry sector does Fluidigm operate in?
Fluidigm operates in the LAB ANALYTICAL INSTRUMENTS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
DMNDamon Inc
US$ 0.2623
(46.78%)
5.68M
SGBXSafe and Green Holdings Corporation
US$ 0.7664
(40.47%)
1.2M
CMNDClearmind Medicine Inc
US$ 1.50
(32.74%)
403
FTAIFTAI Aviation Ltd
US$ 125.08
(21.15%)
1
INTWGraniteShares 2X Long INTC Daily ETF
US$ 23.99
(20.86%)
8.27k
ADTXAditxt Inc
US$ 0.0327
(-42.43%)
556.39k
ULYUrgent ly Inc
US$ 0.3688
(-27.63%)
741
LIVNLivaNova PLC
US$ 30.00
(-23.21%)
202
HEPAHepion Pharmaceuticals Inc
US$ 0.038
(-22.13%)
128.78k
MKDWMKDWELL Tech Inc
US$ 0.3723
(-17.65%)
39
DMNDamon Inc
US$ 0.2623
(46.78%)
5.68M
SGBXSafe and Green Holdings Corporation
US$ 0.7664
(40.47%)
1.2M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.05
(-0.98%)
1.14M
SHViShares Short Treasury Bond ETF
US$ 110.24
(0.01%)
719.85k
ADTXAditxt Inc
US$ 0.0327
(-42.43%)
556.39k

FLDM Discussion

게시물 보기
manysevens manysevens 3 년 전
FLDM bot this 30 min chart today..

👍️0
Eggplant Eggplant 3 년 전
No. I think they are in deep doo doo. They just held their Q3 conference call, and took ZERO questions. What's that about? I think that level of silence speaks volumes. It looks like they are burning more than $10m of cash a quarter, with only $30m of cash remaining - but it's really only $20m if you net out the $10m of cash borrowed from Silicon Valley Bank term loan during the quarter. The working capital #'s are starting to look a bit strange: sales down, and A/R down commensurately, BUT Inventories UP, and A/P UP! It sure looks like they are stretching their payables. Who wants to do the A/P days calculation? Who wants to read the SVB loan agreement to see if covenants were tripped, or will be shortly?

On 7/27/21 Bloomberg reported that FLDM was working with an advisor and speaking to potential buyers of the company. That was 3 months ago, and: nothing. So today they announce a "Strategic Review . . . to maximize shareholder value". This looks like the trajectory of a distressed company, doesn't it?
👍️0
LongTimeObserver LongTimeObserver 4 년 전
$FLDM Back from the dead?
👍️0
LongTimeObserver LongTimeObserver 4 년 전
Pffft! $FLDM
👍️0
Atlanta1 Atlanta1 4 년 전
06:28
$FLDM
Fluidigm: Trump Administration provides saliva test at surge testing site in Waco, TX (6.75)
"Starting today, communities that are part of the federal surge testing effort for COVID-19, supported by the Trump Administration, have a new option: a test that uses samples of saliva collected by spitting into a sterile container. Made by Fluidigm Corporation and supported in part by the National Institutes of Health (NIH), the easy-to-use saliva test detects SARS-CoV-2, the virus that causes COVID-19, on a molecular level using a microfluidics platform. The accuracy of the test is comparable to other molecular-level tests of nasal swab samples, according to a clinical study conducted by the manufacturer. The U.S. Department of Health and Human Services (HHS) has traditionally provided nasal swab tests from other manufacturers to surge testing sites, which remain a choice for community officials."

https://www.hhs.gov/about/news/2020/10/16/trump-administration-provides-saliva-test-at-surge-testing-site-in-waco-tx.html
👍️0
Ckasper Ckasper 4 년 전
Don’t want to jinx it, but currently the stock is up 90%. Hope that means we’ll see a big gap opening tomorrow.
👍️0
Ckasper Ckasper 4 년 전
Does anybody know, when they are expecting the NHI approval and what is still open regarding the approval?
👍️0
lakingsphan0427 lakingsphan0427 5 년 전
The retarded Newscum of Khalifhurnia should do the same..

Patience is the key here..
👍️0
Hole shot King Hole shot King 5 년 전
Fluidigm Corporation (Nasdaq: $FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced progress on the Company’s Rapid Acceleration of Diagnostics (RADx) project.

https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83214731/fluidigm-achieves-initial-milestone-under-nih-rapi
👍️0
Hole shot King Hole shot King 5 년 전
8K Item 8.01. Other Events.



From August 13, 2020 through September 3, 2020, Fluidigm Corporation (the “Company”) sold a total of 2,479,517 shares of its common stock for aggregate gross proceeds of approximately $20.9 million before commissions and offering expenses under its previously announced “at-the-market” equity offering program. The sales were completed pursuant to the Open Market Sale AgreementSM with Jefferies LLC dated as of March 4, 2020, which the Company filed as an exhibit to a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 5, 2020.


https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83213327/current-report-filing-8-k
👍️0
Ckasper Ckasper 5 년 전
NEWS OUT.
FLDM fulfills first step of NHI requirements.
👍️0
Hole shot King Hole shot King 5 년 전
The Law Offices of Frank R. Cruz Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors $FLDM https://newsfilter.io/a/0a76fc698a3e38b64c511d5e5683326e
👍️0
Hole shot King Hole shot King 5 년 전
$FLDM should have a good bounce
👍️0
Ckasper Ckasper 5 년 전
Keep it coming. Gotta be patient
👍️0
Hole shot King Hole shot King 5 년 전
$FLDM Gov of Missouri is working in the "coming weeks" to roll out the saliva based test to all Missouri citizens
👍️0
Hole shot King Hole shot King 5 년 전
$FLDM Governor to talk saliva-based COVID-19 test https://www.newspressnow.com/news/regional_news/central_missouri/governor-to-talk-saliva-based-covid-19-test/article_aa493c13-9d63-561b-a78c-e66218ec79e4.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via @newspressnow
👍️0
Ckasper Ckasper 5 년 전
Quick testing is still highly demanded. Especially with schools starting now.
👍️0
jonsmile jonsmile 5 년 전
Not sure it might be over it’s all about the cure now
👍️0
Ckasper Ckasper 5 년 전
Agree. That’s why I’m saying it’s going up from here.
👍️0
jonsmile jonsmile 5 년 전
This entire sector has been down

OPK as well
👍️0
Ckasper Ckasper 5 년 전
You here for short gains? That streak would be over now ;)
👍️0
jonsmile jonsmile 5 년 전
LOL counting those chickens I see
👍️0
Ckasper Ckasper 5 년 전
For now
👍️0
jonsmile jonsmile 5 년 전
But it’s red LOL
👍️0
Ckasper Ckasper 5 년 전
Today is the turnaround. First Green Day in a week. Up from here.
👍️0
Ckasper Ckasper 5 년 전
They’ll have to bring out news soon. Implementation in colleges and schools would be the perfect news.
👍️0
lakingsphan0427 lakingsphan0427 5 년 전
Added a few more here..
👍️0
rstar rstar 5 년 전
NIH grant monies and full approval coming next i think- also usage data will hopefully show detection earlier than other tests and greater accuracy $FLDM
👍️0
Ckasper Ckasper 5 년 전
It’ll jump next week again, if they bring out an official statement.
👍️0
Hole shot King Hole shot King 5 년 전
$FLDM

ECHO performer, @fluidigm, has been awarded Emergency Use Authorization (EUA) by the FDA for their saliva-based COVID-19 test. Their microfluidics platform, developed with support from DARPA, has a capacity to conduct up to 6,000 tests per day per system. https://t.co/rE5iNK57wU pic.twitter.com/spb2TvJYDO— DARPA (@DARPA) August 28, 2020

👍️0
Hole shot King Hole shot King 5 년 전
$FLDM Interview on Washington University's new Saliva COVID test

Rich Head, MS, Director, Genome Technology Access Center,
@GenomeInstitute
, discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.


Rich Head, MS, Director, Genome Technology Access Center, @GenomeInstitute, discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.https://t.co/XEfuhGUsIf— Standard BioTools (@Standard_BioT) August 29, 2020


👍️0
lakingsphan0427 lakingsphan0427 5 년 전
Just added a few more today..
👍️0
Ckasper Ckasper 5 년 전
I like it. Great find
👍️0
Hole shot King Hole shot King 5 년 전
twitter https://www.marketbeat.com/instant-alerts/nasdaq-fldm-a-buy-or-sell-right-now-2020-08/

https://twitter.com/ZolmaxNews


https://zolmax.com/investing/fluidigm-nasdaqfldm-price-target-raised-to-16-00-at-ubs-group/4690037.html

$FLDM
👍️0
Ckasper Ckasper 5 년 전
Where did you see that?
👍️0
lakingsphan0427 lakingsphan0427 5 년 전
Sounds good to me..
👍️0
Hole shot King Hole shot King 5 년 전
Fluidigm $FLDM Price Target Raised to $16.00 at UBS Group
👍️0
Ckasper Ckasper 5 년 전
Hoping for a good post market move, so we can see some additional gain tomorrow.
👍️0
Inspector121 Inspector121 5 년 전
Never stop learning lessons. Priceless.
👍️0
Ckasper Ckasper 5 년 전
I rarely pick it right either, but this was pretty obvious. Thx for the kudos ;)
👍️0
Inspector121 Inspector121 5 년 전
Great call. Wish I had the knowledge to be able to see these things. Thanks
👍️0
Inspector121 Inspector121 5 년 전
Accuracy of that test is questionable. But BP can get away with it. Rigged system. Money talks and FDA listens.
👍️0
lakingsphan0427 lakingsphan0427 5 년 전
WHOA! my $7.65 buys this morning starts to look good..

$20 or better by end of year..
👍️0
Runners123 Runners123 5 년 전
That was a fleeting moment of hype, now a new test is approved that costs $5 and takes 5 minutes for results.
👍️0
Daddy Rick Daddy Rick 5 년 전
I'm at an avg. of $9.41 and feel good about it.

Thinking anything under $10.00 is a REALLY GREAT investment here. BWDIK lol
👍️0
sfast900 sfast900 5 년 전
Bittersweet, I was fine with 1000 shares at 10.
I guess 3200 is what it needed.
Try to get my shares NOW... LOL
👍️0
Ckasper Ckasper 5 년 전
It’ll bottom at 7.50. Then go back to around 9 in the afternoon.
👍️0
Daddy Rick Daddy Rick 5 년 전
Thank You.
👍️0
Inspector121 Inspector121 5 년 전
Abbott tests highly inaccurate.
👍️0
ib12u ib12u 5 년 전
Is this worth getting into? Looks like it took a fall at the opening..
👍️0

최근 히스토리

NASDAQ
FLDM
Fluidigm
ASX
AO3HC
Apollo Series 2018 1
USOTC
KGGNF
Kogan com (PK)
CSE
PXI
Planet Ventures
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지